Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

farmak international sp. z o.o., poľsko - moxonidín - 58 - hypotensiva

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

farmak international sp. z o.o., poľsko - moxonidín - 58 - hypotensiva

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

farmak international sp. z o.o., poľsko - moxonidín - 58 - hypotensiva

Európska únia - slovenčina - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresíva - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.

Európska únia - slovenčina - EMA (European Medicines Agency)

ucb pharma s.a. - lakosamid - epilepsie, čiastočná - antiepileptiká, - lacosamide spoločnosti ucb je označené ako monotherapy a adjunctive terapie v liečbe čiastočné-nástup záchvaty s alebo bez sekundárnej zovšeobecnenie v dospelí, mladiství a deti od 4 rokov s epilepsiou.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dr. müller pharma s.r.o., Česká republika - paracetamol, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

xantis pharma limited, cyprus - paracetamol, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica

Európska únia - slovenčina - EMA (European Medicines Agency)

ucb pharma s.a. - romosozumab - osteoporóza - lieky na liečbu chorôb kostí - evenity je indikovaný v liečbe ťažkej osteoporózy u postmenopauzálnych žien s vysokým rizikom zlomeniny.

Európska únia - slovenčina - EMA (European Medicines Agency)

ucb pharma s.a.   - bimekizumab - svrab - imunosupresíva - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.

Európska únia - slovenčina - EMA (European Medicines Agency)

intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - imunologické pomôcky pre koňovité - kone - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.